Subcutaneous mosunetuzumab is active with a manageable safety profile in patients (pts) with relapsed/refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs): Updated results from a phase I/II study Meeting Abstract
| Authors: | Budde, E. L.; Bartlett, N. L.; Giri, P.; Schuster, S. J.; Assouline, S.; Yoon, S. S.; Fay, K.; Matasar, M. J.; Gutierrez, N. C.; Marlton, P.; Dreyling, M.; Yoon, D. H.; Hess, G.; Radford, J.; Wiebking, V.; Yin, S.; Cybulski, E.; Turner, D. C.; Huang, H.; Zhou, M.; Penuel, E.; Wei, M. C.; Sehn, L. H. |
| Abstract Title: | Subcutaneous mosunetuzumab is active with a manageable safety profile in patients (pts) with relapsed/refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs): Updated results from a phase I/II study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 3753 |
| End Page: | 3755 |
| Language: | English |
| ACCESSION: | WOS:000893223203346 |
| DOI: | 10.1182/blood-2022-157729 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
